News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MDxHealth, Inc. (MXDHF) Secures Coverage For Prostate Cancer Test With Two Additional Insurance Companies



12/2/2013 9:53:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif. and HERSTAL, Belgium, Dec. 2, 2013 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced that it has signed agreements with HealthSmart, a Preferred Provider Organization (PPO) network, and Fortified Provider Network to provide their members access to the ConfirmMDx® for Prostate Cancer test. The addition of these agreements extends ConfirmMDx for Prostate Cancer testing to more than 135 million insurance covered lives throughout the U.S.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES